Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 13

Results For "ether"

1384 News Found

Insmed’s Brensocatib fails to hit endpoints in hidradenitis suppurativa study
News | April 09, 2026

Insmed’s Brensocatib fails to hit endpoints in hidradenitis suppurativa study

The results were consistent across both the 10 mg and 40 mg treatment arms


JP Nadda highlights preventive healthcare push on World Health Day
Policy | April 08, 2026

JP Nadda highlights preventive healthcare push on World Health Day

Union Health Minister says India’s healthcare model blends traditional wisdom with modern science, backed by Ayushman Bharat and Janaushadhi expansion


Trialt and Viedoc team up to transform clinical trials
Clinical Trials | April 08, 2026

Trialt and Viedoc team up to transform clinical trials

The partnership aims to accelerate clinical trial timelines, boost data quality, and improve decision-making for sponsors worldwide


Transgene and NEC join forces to advance personalized cancer vaccine
R&D | April 08, 2026

Transgene and NEC join forces to advance personalized cancer vaccine

TG4050 harnesses Transgene’s myvac platform and NEC’s AI-powered neoantigen prediction technology to tailor vaccines to each patient’s tumor


Regeneron and TriNetX forge $200M partnership to supercharge drug discovery and digital health
News | April 08, 2026

Regeneron and TriNetX forge $200M partnership to supercharge drug discovery and digital health

TriNetX will provide Regeneron secure, licensed access to de-identified health data from its global network of health system partners


OneCyte and Kemp Proteins to revolutionize cell line development
Biopharma | April 08, 2026

OneCyte and Kemp Proteins to revolutionize cell line development

Biopharma companies face persistent hurdles in cell line development, including long timelines, low yields, and high failure rates for novel molecules


Moderna to reveal late-breaking data on flu & RSV mRNA vax at ESCMID 2026
Clinical Trials | April 08, 2026

Moderna to reveal late-breaking data on flu & RSV mRNA vax at ESCMID 2026

The data will be presented at the 2026 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress in Munich, April 17-21


Neurocrine Biosciences to acquire Soleno Therapeutics for $2.9 billion
News | April 08, 2026

Neurocrine Biosciences to acquire Soleno Therapeutics for $2.9 billion

The acquisition adds VYKAT XR (diazoxide choline), the first FDA-approved therapy for hyperphagia in Prader-Willi syndrome (PWS), a rare genetic disorder, to Neurocrine’s portfolio


HRV Pharma, Shodhana join hands to build next-gen API pipeline for global markets
News | April 07, 2026

HRV Pharma, Shodhana join hands to build next-gen API pipeline for global markets

Multi-year CDMO partnership combines AI-led virtual development, precision chemistry and GMP manufacturing to accelerate five high-science APIs across regulated markets